Viewing Study NCT04726033


Ignite Creation Date: 2025-12-25 @ 2:47 AM
Ignite Modification Date: 2026-01-01 @ 5:02 AM
Study NCT ID: NCT04726033
Status: COMPLETED
Last Update Posted: 2024-05-01
First Post: 2020-10-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: 64Cu-TLX592 Phase I Safety, PK, Biodistribution and Dosimetry Study (CUPID Study)
Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module